TARGET AUDIENCE
This accredited activity has been designed for pharmacists.
GOAL
The goal of this activity is to educate pharmacists about the pharmacologic treatment of elevated low-density lipoprotein cholesterol and triglycerides based on updated guideline recommendations and recent clinical trial evidence so that pharmacists can effectively collaborate with patients and prescribers to improve patients’ lipid and cardiovascular outcomes.
LEARNING OBJECTIVES
Upon completion of this program, participants should be better able to:
- Summarize the safety, tolerability, and cardiovascular benefits of medications approved to reduce low-density lipoprotein cholesterol and triglycerides
- Review recommendations for lipid-lowering therapy for reducing low-density lipoprotein cholesterol and triglycerides based on updated guidelines and recent clinical trial evidence
- Identify how to collaborate with patients and prescribers to optimize lipid-lowering therapy
Postgraduate Healthcare Education, LLC ("PHE") provides Power-Pak C.E.® educational programs for the broad spectrum of healthcare professions. Professional medical and pharmaceutical education constitutes PHE's core activity. PHE continues to successfully produce continuing education programs for all professional healthcare disciplines including pharmacists, pharmacy technicians, physicians, nurses, physician assistants, and nurse practitioners.
